Mankind Pharma Announces 35th AGM on August 4, 2026
Mankind Pharma Limited will hold its 35th Annual General Meeting (AGM) on August 4, 2026, at 3:30 PM IST via Video Conference. The company has published newspaper advertisements and will provide AGM notice and annual reports electronically to registered members. E-voting facilities will be available.
This is a standard corporate event (AGM) and does not involve any new financial outcomes, strategic changes, or material events that would directly impact the company's stock price or business operations in the short term.
The announcement is a routine disclosure regarding the Annual General Meeting and does not contain any new financial information or significant business developments that would impact the company's valuation.
Mankind Pharma Limited has announced that its 35th Annual General Meeting (AGM) will be held on Tuesday, August 4, 2026, at 03:30 PM (IST). The meeting will be conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM).
The company has published advertisements regarding the AGM in "Financial Express" (English) and "Jansatta" (Hindi) on July 1, 2026. The Notice of the AGM and the Annual Report for the Financial Year 2025-26 will be sent via email to members whose email addresses are registered with the company or its Registrar and Share Transfer Agent (RTA), KFin Technologies Limited, or their respective Depository Participants (DPs). These documents will also be available on the company's website, the websites of BSE and NSE, and the website of Central Depository Services (India) Limited (CDSL).
Members who have not registered their email addresses will receive a web link to the company's website where the Notice and Annual Report are available. The company has stated that its entire shareholding is in dematerialized form, and members are advised to update their email addresses with their DPs. Members can also request a hard copy of the Notice of AGM and Annual Report by emailing investors@mankindpharma.com.
The facility for remote e-voting (prior to the AGM) and e-voting (during the AGM) will be made available. Detailed instructions for joining the AGM via VC/OAVM and for e-voting will be provided in the Notice of the AGM. CDSL has been appointed as the agency to provide the e-voting facility, and contact details for queries have been provided.
What to do with a filing like this
Mankind Pharma Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mankind Pharma Limited. Read the original for the full detail.